News

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
HANGZHOU (Reuters) -China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental ...
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.
The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...
Doses of Wegovy, a drug used for weight loss, are stored in a refrigerator at Donna Cooper’s home in Front Royal, Va., on Friday, March 1, 2024.
This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...